#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Granulomatosis with polyangiitis Neuroendocrine tumour Liposarcoma recurrent Pleomorphic leiomyosarcoma Gastrointestinal stromal tumour Primary amyloidosis Paraganglion neoplasm Dupuytren's contracture Synovial sarcoma Polyneuropathy Anal fistula Gastrooesophageal cancer Renal disorder Pleomorphic liposarcoma Haemolytic uraemic syndrome More trials…

    Learn about Rare Diseases

    Mastocytosis Lymphangiosarcoma – Trials in Disease Lysosomal storage disorder Rosai-Dorfman syndrome – Life with Disease Activated PI3 kinase delta syndrome – Life with Disease Mantle cell lymphoma stage II – Trials in Disease Metachromatic leukodystrophy Myelodysplastic syndrome – Trials in Disease Advanced systemic mastocytosis – Trials in Disease Mantle cell lymphoma stage IV More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Resiquimod Sulfate Irinotecan Rbl016.2 Itolizumab Bjt-778 Cellulose, Microcrystalline Hydroxocobalamin Erythromycin Tadalafil VG801-2 Mva-Hbvac TX000045 Altizide Antithrombin Iii Human Epinephrine Bitartrate Cefalexin Monohydrate SP16 Dextromethorphan Hydrobromide Capsaicin LUXDEGALUTAMIDE More therapies…

    Learn about Your Condition

    Herpes simplex Procedural pain Acute respiratory failure Retinal artery occlusion Tardive dyskinesia Malabsorption Habitual abortion Follicular lymphoma Angiosarcoma metastatic Procedural anxiety Torticollis Fragile X syndrome Epicondylitis Poor quality sleep Laryngeal cancer stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Debio 0123 and Temozolomide for Adults with Recurrent or Newly Diagnosed Glioblastoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • 3-(2,6-Dichlorophenyl)-2,3-Dihydro-1-Methyl-7-[[3-Methyl-4-(1-Methyl-4-Piperidinyl)Phenyl]Amino]-Pyrimido[4,5-D]Pyrimidin-4(1H)-One
    • Tolu Balsam
    • Bromhexine Hydrochloride
    Spain

  • Study Comparing Mosunetuzumab and Lenalidomide with Other Treatments for Patients with Relapsed or Refractory Marginal Zone Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Mosunetuzumab
    • Bendamustine Hydrochloride
    • Cyclophosphamide
    Belgium France Germany Italy Portugal

  • Study on Long-Term Safety of Secukinumab for Patients with Psoriatic Arthritis, Ankylosing Spondylitis, and Severe Chronic Plaque Psoriasis

    Recruiting

    3 1 1 1 1
    Investigated Drugs:
    • Secukinumab
    Belgium Bulgaria Czechia Germany Italy Poland +2

  • Study on the Safety and Effectiveness of Upadacitinib and Dupilumab for Children Aged 2 to 12 with Moderate to Severe Atopic Dermatitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Dupilumab
    • Upadacitinib
    Austria Bulgaria Croatia France Germany Hungary +6

  • Efficacy and Safety of Lucerastat in Treatment‑Naïve Adult Male Patients with Fabry Disease

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Fabry’s disease
    Investigated Drugs:
    • Lucerastat
    France Germany

  • Prehospital Sedation with Esketamine versus Propofol in Patients with Severe Acute Brain Injury

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Brain injury
    • Cerebral haemorrhage
    • Craniocerebral injury
    Investigated Drugs:
    • Esketamine Hydrochloride
    • Propofol
    Denmark
Previous Page
1 … 653 654 655 656 657 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!